Patents by Inventor Marwan El-Sabban

Marwan El-Sabban has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230149147
    Abstract: A mesh implant is disclosed and comprises a single sheet, highly porous, adhesion-resistant, tensile surgical implant composed of a gradually biodegradable synthetic polymer material that is electrospun into nanofibers and randomly stacked to form a three-dimensional (3D) mesh. The mesh implant is for tissue repair and hernia repair. The single-sheet design reduces the foreign material that make up the mesh implant, which minimizes mesh implant rejection. The gradually biodegradable nature of the mesh implant guarantees that the mesh stays in place and supports the repaired site long enough until a proper scar tissue has built up, after which the mesh implant disappears from the body, therefore preventing pain and irritability. The 3D design of the nanofibrous network and the high porosity of the mesh implant facilitate cell attachment, infiltration, and proliferation, all necessary for scar tissue formation, mesh integration, wound healing, and proper defect closure.
    Type: Application
    Filed: November 9, 2022
    Publication date: May 18, 2023
    Inventors: Ramzi Alami, Ali Tehrani, Marwan El Sabban
  • Publication number: 20200037588
    Abstract: As disclosed herein, the invention relates to a method of screening for a therapeutic for chronic myeloid leukemia. In an aspect, the invention relates to transgenic Drosophila. In an aspect, the invention relates to a Drosophila system for screening compounds treating chronic myeloid leukemia.
    Type: Application
    Filed: August 1, 2019
    Publication date: February 6, 2020
    Inventors: Rihab Nasr, Margret Shirinian, Amani Al-Outa, Ali Bazarbachi, Marwan El-Sabban
  • Publication number: 20120065620
    Abstract: There is provided a method and use of hematopoietic stem cells for the treatment of various diseases. The differentiation of autologueous hematopoietic stem cells into myeloid lineages is used for reintroduction into a patient in addition to undifferentiated stem cells for the purpose of reconstituting both the defence and long-term engraftment.
    Type: Application
    Filed: June 18, 2010
    Publication date: March 15, 2012
    Applicant: MC2 Cell ApS
    Inventor: Marwan El-Sabban
  • Publication number: 20110207175
    Abstract: There is provided co-culture bioreactor systems that can maintain stem cells and differentiated cell types in physically isolated environments but can allow biochemical communication between these cells. For instance, a co-culture bioreactor system of the present invention can include a first culture chamber that defines a first inlet and a first outlet such that fluid can flow through the culture chamber. The system can also include a second culture chamber defining a second inlet and a second outlet allowing a second fluid flow through this second chamber. The system can also include a semi-permeable membrane. The semi-permeable membrane can be located between the first culture chamber and the second culture chamber.
    Type: Application
    Filed: October 2, 2009
    Publication date: August 25, 2011
    Applicant: MC2 Cell ApS
    Inventors: Marwan El-Sabban, Steen Sindet-Pedersen